Evaluation of in vitro screening system for estrogenicity : comparison of stably transfected human estrogen receptor-α transcriptional activation (OECD TG455) assay and estrogen receptor (ER) binding assay
-
- Lee Hae Kyung
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kim Tae Sung
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kim Chang Yeong
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kang Il Hyun
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kim Mi Gyeong
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kyung Jung Ki
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Kim Hyung Sik
- College of Pharmacy, Pusan National University, Korea
-
- Han Soon Young
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Yoon Hae Jung
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
-
- Rhee Gyu Seek
- Health Effects Analysis Team, National Institute of Food and Drug Safety Evaluation, Korea
書誌事項
- タイトル別名
-
- Evaluation of <i>in vitro</i> screening system for estrogenicity: comparison of stably transfected human estrogen receptor-α transcriptional activation (OECD TG455) assay and estrogen receptor (ER) binding assay
この論文をさがす
抄録
The estrogenic activity of industrial chemicals, di(2-ethylhexyl) phthalate (DEHP), di(n-butyl) phthalate (DBP), benzylbutyl phthalate (BBP), diethyl phthalate (DEP), tetrabromobisphenol A (TBBPA), bisphenol A (BPA), and nonylphenol (NP), was compared using OECD test guideline 455(TG455), stably transfected transcriptional activation (STTA) and estrogen receptor (ER) binding assays. The estrogenic activity of BBP, BPA and NP were approximately 180,000-fold (PC50, 4.32 x 10-6 M), 5,000-fold (PC50, 1.26 x 10-7 M) and 120,000-fold (PC50, 2.92 x 10-6 M) less than 17β-estradiol (PC50, 2.43 x 10-11M), whereas DEHP, DBP and DEP did not show any estrogenicity activity in the STTA assay. Moreover, binding affinities to human ERα of BBP, BPA, and NP were approximately 200,000-fold (IC50, 4.91 x 10-4 M), 8000-fold (IC50, 1.92 x 10-5 M) and 1400-fold (IC50, 3.34 x 10-6 M) less than 17β-estradiol (IC50, 2.45 x 10-9 M) in competitive human ERα binding assay. The relative potencies of STTA assay were very similar to ER binding, E-screen, and Yeast screening assays. Therefore, our results suggested that OECD test guideline TG455 may be useful as a screening test for potential endocrine disruptors.
収録刊行物
-
- The Journal of Toxicological Sciences
-
The Journal of Toxicological Sciences 37 (2), 431-437, 2012
一般社団法人 日本毒性学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204903679616
-
- NII論文ID
- 10030127105
-
- NII書誌ID
- AN00002808
-
- COI
- 1:CAS:528:DC%2BC38XotVylur8%3D
-
- ISSN
- 18803989
- 03881350
-
- NDL書誌ID
- 023674847
-
- PubMed
- 22467034
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可